APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quinolone Antibiotic

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Quinolone Antibiotic Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchQuinolone Antibiotic Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Quinolone Antibiotic Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Quinolone Antibiotic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quinolone Antibiotic Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Quinolone Antibiotic Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Quinolone Antibiotic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Quinolone Antibiotic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quinolone Antibiotic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quinolone Antibiotic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Quinolone Antibiotic market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Quinolone Antibiotic market include Merck, Hebei Guangren Pharmaceutical Technology, Tianjin Glory Technology, Mercury Medicare and Healthy Life Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quinolone Antibiotic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quinolone Antibiotic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quinolone Antibiotic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quinolone Antibiotic market size, projected growth trends, production technologies, key applications, and end-use industries.

Quinolone Antibiotic Segment by Company

Merck

Hebei Guangren Pharmaceutical Technology

Tianjin Glory Technology

Mercury Medicare

Healthy Life Pharma

Quinolone Antibiotic Segment by Type

Levofloxacin

Ofloxacin

Norfloxacin

Moxifloxacin

Gatifloxacin

Ciprofloxacin

Others

Quinolone Antibiotic Segment by Application

Clinics

Hospital

Research

Others

Quinolone Antibiotic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Quinolone Antibiotic status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Quinolone Antibiotic market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Quinolone Antibiotic significant trends, drivers, influence factors in global and regions.

6. To analyze Quinolone Antibiotic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolone Antibiotic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quinolone Antibiotic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolone Antibiotic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quinolone Antibiotic market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quinolone Antibiotic industry.

Chapter 3: Detailed analysis of Quinolone Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Quinolone Antibiotic in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Quinolone Antibiotic Industry Trends Table 2. Quinolone Antibiotic Industry Drivers Table 3. Quinolone Antibiotic Industry Opportunities and Challenges Table 4. Quinolone Antibiotic Industry Restraints Table 5. Global Quinolone Antibiotic Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Quinolone Antibiotic Revenue Share by Company (2021-2026) Table 7. Global Quinolone Antibiotic Sales Volume by Company (tons) & (2021-2026) Table 8. Global Quinolone Antibiotic Sales Volume Share by Company (2021-2026) Table 9. Global Quinolone Antibiotic Average Price (US$/ton) of Company (2021-2026) Table 10. Global Quinolone Antibiotic Company Ranking, (2024-2026) & (USD Million) Table 11. Global Quinolone Antibiotic Key Company Manufacturing Base & Headquarters Table 12. Global Quinolone Antibiotic Company, Product Type & Application Table 13. Global Quinolone Antibiotic Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Quinolone Antibiotic by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Levofloxacin Table 18. Significant Companies of Ofloxacin Table 19. Significant Companies of Norfloxacin Table 20. Significant Companies of Moxifloxacin Table 21. Significant Companies of Gatifloxacin Table 22. Significant Companies of Ciprofloxacin Table 23. Significant Companies of Others Table 24. Global Quinolone Antibiotic Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 25. Global Quinolone Antibiotic Sales Volume by Type (2021-2026) & (tons) Table 26. Global Quinolone Antibiotic Sales Volume by Type (2027-2032) & (tons) Table 27. Global Quinolone Antibiotic Sales Volume Share by Type (2021-2026) Table 28. Global Quinolone Antibiotic Sales Volume Share by Type (2027-2032) Table 29. Global Quinolone Antibiotic Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Quinolone Antibiotic Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Quinolone Antibiotic Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Quinolone Antibiotic Sales Value Share by Type (2021-2026) Table 33. Global Quinolone Antibiotic Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Clinics Table 35. Significant Companies of Hospital Table 36. Significant Companies of Research Table 37. Significant Companies of Others Table 38. Global Quinolone Antibiotic Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 39. Global Quinolone Antibiotic Sales Volume by Application (2021-2026) & (tons) Table 40. Global Quinolone Antibiotic Sales Volume by Application (2027-2032) & (tons) Table 41. Global Quinolone Antibiotic Sales Volume Share by Application (2021-2026) Table 42. Global Quinolone Antibiotic Sales Volume Share by Application (2027-2032) Table 43. Global Quinolone Antibiotic Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Quinolone Antibiotic Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Quinolone Antibiotic Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Quinolone Antibiotic Sales Value Share by Application (2021-2026) Table 47. Global Quinolone Antibiotic Sales Value Share by Application (2027-2032) Table 48. Global Quinolone Antibiotic Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 49. Global Quinolone Antibiotic Sales by Region (2021-2026) & (tons) Table 50. Global Quinolone Antibiotic Sales Market Share by Region (2021-2026) Table 51. Global Quinolone Antibiotic Sales by Region (2027-2032) & (tons) Table 52. Global Quinolone Antibiotic Sales Market Share by Region (2027-2032) Table 53. Global Quinolone Antibiotic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Quinolone Antibiotic Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Quinolone Antibiotic Sales Value Share by Region (2021-2026) Table 56. Global Quinolone Antibiotic Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Quinolone Antibiotic Sales Value Share by Region (2027-2032) Table 58. Global Quinolone Antibiotic Market Average Price (US$/ton) by Region (2021-2026) Table 59. Global Quinolone Antibiotic Market Average Price (US$/ton) by Region (2027-2032) Table 60. Global Quinolone Antibiotic Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 61. Global Quinolone Antibiotic Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Quinolone Antibiotic Sales by Country (2021-2026) & (tons) Table 63. Global Quinolone Antibiotic Sales Market Share by Country (2021-2026) Table 64. Global Quinolone Antibiotic Sales by Country (2027-2032) & (tons) Table 65. Global Quinolone Antibiotic Sales Market Share by Country (2027-2032) Table 66. Global Quinolone Antibiotic Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Quinolone Antibiotic Sales Value Market Share by Country (2021-2026) Table 68. Global Quinolone Antibiotic Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Quinolone Antibiotic Sales Value Market Share by Country (2027-2032) Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Quinolone Antibiotic Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Merck Quinolone Antibiotic Product Portfolio Table 74. Merck Recent Development Table 75. Hebei Guangren Pharmaceutical Technology Company Information Table 76. Hebei Guangren Pharmaceutical Technology Business Overview Table 77. Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Product Portfolio Table 79. Hebei Guangren Pharmaceutical Technology Recent Development Table 80. Tianjin Glory Technology Company Information Table 81. Tianjin Glory Technology Business Overview Table 82. Tianjin Glory Technology Quinolone Antibiotic Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Tianjin Glory Technology Quinolone Antibiotic Product Portfolio Table 84. Tianjin Glory Technology Recent Development Table 85. Mercury Medicare Company Information Table 86. Mercury Medicare Business Overview Table 87. Mercury Medicare Quinolone Antibiotic Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Mercury Medicare Quinolone Antibiotic Product Portfolio Table 89. Mercury Medicare Recent Development Table 90. Healthy Life Pharma Company Information Table 91. Healthy Life Pharma Business Overview Table 92. Healthy Life Pharma Quinolone Antibiotic Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Healthy Life Pharma Quinolone Antibiotic Product Portfolio Table 94. Healthy Life Pharma Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Quinolone Antibiotic Distributors List Table 98. Quinolone Antibiotic Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Quinolone Antibiotic Product Image Figure 2. Global Quinolone Antibiotic Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 4. Global Quinolone Antibiotic Sales (2021-2032) & (tons) Figure 5. Global Quinolone Antibiotic Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Quinolone Antibiotic Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Levofloxacin Image Figure 10. Ofloxacin Image Figure 11. Norfloxacin Image Figure 12. Moxifloxacin Image Figure 13. Gatifloxacin Image Figure 14. Ciprofloxacin Image Figure 15. Others Image Figure 16. Global Quinolone Antibiotic Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 17. Global Quinolone Antibiotic Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Quinolone Antibiotic Sales Volume Share by Type (2021-2032) Figure 19. Global Quinolone Antibiotic Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Quinolone Antibiotic Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Quinolone Antibiotic Sales Value Share by Type (2021-2032) Figure 22. Clinics Image Figure 23. Hospital Image Figure 24. Research Image Figure 25. Others Image Figure 26. Global Quinolone Antibiotic Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 27. Global Quinolone Antibiotic Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Quinolone Antibiotic Sales Volume Share by Application (2021-2032) Figure 29. Global Quinolone Antibiotic Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Quinolone Antibiotic Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Quinolone Antibiotic Sales Value Share by Application (2021-2032) Figure 32. Global Quinolone Antibiotic Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 33. Global Quinolone Antibiotic Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Quinolone Antibiotic Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Quinolone Antibiotic Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 37. North America Quinolone Antibiotic Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Quinolone Antibiotic Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Quinolone Antibiotic Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 43. South America Quinolone Antibiotic Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Quinolone Antibiotic Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Quinolone Antibiotic Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Quinolone Antibiotic Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Quinolone Antibiotic Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Quinolone Antibiotic Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Levofloxacin
  • Ofloxacin
  • Norfloxacin
  • Moxifloxacin
  • Gatifloxacin
  • Ciprofloxacin
  • Others
Applications
  • Clinics
  • Hospital
  • Research
  • Others
Companies covered
  • Merck
  • Hebei Guangren Pharmaceutical Technology
  • Tianjin Glory Technology
  • Mercury Medicare
  • Healthy Life Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quinolone Antibiotic Sales Value (2021-2032)
  4. 1.2.2 Global Quinolone Antibiotic Sales Volume (2021-2032)
  5. 1.2.3 Global Quinolone Antibiotic Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Quinolone Antibiotic Market Dynamics
  1. 2.1 Quinolone Antibiotic Industry Trends
  2. 2.2 Quinolone Antibiotic Industry Drivers
  3. 2.3 Quinolone Antibiotic Industry Opportunities and Challenges
  4. 2.4 Quinolone Antibiotic Industry Restraints
3 Quinolone Antibiotic Market by Company
  1. 3.1 Global Quinolone Antibiotic Company Revenue Ranking in 2025
  2. 3.2 Global Quinolone Antibiotic Revenue by Company (2021-2026)
  3. 3.3 Global Quinolone Antibiotic Sales Volume by Company (2021-2026)
  4. 3.4 Global Quinolone Antibiotic Average Price by Company (2021-2026)
  5. 3.5 Global Quinolone Antibiotic Company Ranking (2024-2026)
  6. 3.6 Global Quinolone Antibiotic Company Manufacturing Base and Headquarters
  7. 3.7 Global Quinolone Antibiotic Company Product Type and Application
  8. 3.8 Global Quinolone Antibiotic Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Quinolone Antibiotic Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Quinolone Antibiotic Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Quinolone Antibiotic Market by Type
  1. 4.1 Quinolone Antibiotic Type Introduction
  2. 4.1.1 Levofloxacin
  3. 4.1.2 Ofloxacin
  4. 4.1.3 Norfloxacin
  5. 4.1.4 Moxifloxacin
  6. 4.1.5 Gatifloxacin
  7. 4.1.6 Ciprofloxacin
  8. 4.1.7 Others
  9. 4.2 Global Quinolone Antibiotic Sales Volume by Type
  10. 4.2.1 Global Quinolone Antibiotic Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Quinolone Antibiotic Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Quinolone Antibiotic Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Quinolone Antibiotic Sales Value by Type
  14. 4.3.1 Global Quinolone Antibiotic Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Quinolone Antibiotic Sales Value by Type (2021-2032)
  16. 4.3.3 Global Quinolone Antibiotic Sales Value Share by Type (2021-2032)
5 Quinolone Antibiotic Market by Application
  1. 5.1 Quinolone Antibiotic Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Research
  5. 5.1.4 Others
  6. 5.2 Global Quinolone Antibiotic Sales Volume by Application
  7. 5.2.1 Global Quinolone Antibiotic Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Quinolone Antibiotic Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Quinolone Antibiotic Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Quinolone Antibiotic Sales Value by Application
  11. 5.3.1 Global Quinolone Antibiotic Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Quinolone Antibiotic Sales Value by Application (2021-2032)
  13. 5.3.3 Global Quinolone Antibiotic Sales Value Share by Application (2021-2032)
6 Quinolone Antibiotic Regional Sales and Value Analysis
  1. 6.1 Global Quinolone Antibiotic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quinolone Antibiotic Sales by Region (2021-2032)
  3. 6.2.1 Global Quinolone Antibiotic Sales by Region: 2021-2026
  4. 6.2.2 Global Quinolone Antibiotic Sales by Region (2027-2032)
  5. 6.3 Global Quinolone Antibiotic Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Quinolone Antibiotic Sales Value by Region (2021-2032)
  7. 6.4.1 Global Quinolone Antibiotic Sales Value by Region: 2021-2026
  8. 6.4.2 Global Quinolone Antibiotic Sales Value by Region (2027-2032)
  9. 6.5 Global Quinolone Antibiotic Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Quinolone Antibiotic Sales Value (2021-2032)
  12. 6.6.2 North America Quinolone Antibiotic Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Quinolone Antibiotic Sales Value (2021-2032)
  15. 6.7.2 Europe Quinolone Antibiotic Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Quinolone Antibiotic Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Quinolone Antibiotic Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Quinolone Antibiotic Sales Value (2021-2032)
  21. 6.9.2 South America Quinolone Antibiotic Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Quinolone Antibiotic Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Quinolone Antibiotic Sales Value Share by Country, 2025 VS 2032
7 Quinolone Antibiotic Country-level Sales and Value Analysis
  1. 7.1 Global Quinolone Antibiotic Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Quinolone Antibiotic Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Quinolone Antibiotic Sales by Country (2021-2032)
  4. 7.3.1 Global Quinolone Antibiotic Sales by Country (2021-2026)
  5. 7.3.2 Global Quinolone Antibiotic Sales by Country (2027-2032)
  6. 7.4 Global Quinolone Antibiotic Sales Value by Country (2021-2032)
  7. 7.4.1 Global Quinolone Antibiotic Sales Value by Country (2021-2026)
  8. 7.4.2 Global Quinolone Antibiotic Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Quinolone Antibiotic Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Quinolone Antibiotic Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Quinolone Antibiotic Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Quinolone Antibiotic Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Quinolone Antibiotic Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Hebei Guangren Pharmaceutical Technology
  8. 8.2.1 Hebei Guangren Pharmaceutical Technology Company Information
  9. 8.2.2 Hebei Guangren Pharmaceutical Technology Business Overview
  10. 8.2.3 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Product Portfolio
  12. 8.2.5 Hebei Guangren Pharmaceutical Technology Recent Developments
  13. 8.3 Tianjin Glory Technology
  14. 8.3.1 Tianjin Glory Technology Company Information
  15. 8.3.2 Tianjin Glory Technology Business Overview
  16. 8.3.3 Tianjin Glory Technology Quinolone Antibiotic Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tianjin Glory Technology Quinolone Antibiotic Product Portfolio
  18. 8.3.5 Tianjin Glory Technology Recent Developments
  19. 8.4 Mercury Medicare
  20. 8.4.1 Mercury Medicare Company Information
  21. 8.4.2 Mercury Medicare Business Overview
  22. 8.4.3 Mercury Medicare Quinolone Antibiotic Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mercury Medicare Quinolone Antibiotic Product Portfolio
  24. 8.4.5 Mercury Medicare Recent Developments
  25. 8.5 Healthy Life Pharma
  26. 8.5.1 Healthy Life Pharma Company Information
  27. 8.5.2 Healthy Life Pharma Business Overview
  28. 8.5.3 Healthy Life Pharma Quinolone Antibiotic Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Healthy Life Pharma Quinolone Antibiotic Product Portfolio
  30. 8.5.5 Healthy Life Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quinolone Antibiotic Value Chain Analysis
  2. 9.1.1 Quinolone Antibiotic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quinolone Antibiotic Sales Mode & Process
  6. 9.2 Quinolone Antibiotic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quinolone Antibiotic Distributors
  9. 9.2.3 Quinolone Antibiotic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst